; Whereas the enactment of the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 ( Public Law 110–293 ; 122 Stat. 2918), and the Comprehensive Tuberculosis Elimination Act of 2008 ( Public Law 110–392 ; 122 Stat. 4195) provided a historic United States commitment to the global eradication of TB, including a commitment to treat 4,500,000 TB patients and 90,000 MDR-TB patients between 2009 and 2013 and to provide additional treatment through coordinated multilateral efforts; Whereas USAID provides financial and technical assistance to 23 countries highly burdened by TB, helps to support the development of new diagnostic and treatment tools, and is authorized to support research to develop new vaccines to combat TB; Whereas TB incidence in the countries that receive bilateral TB funding from the United States through USAID has decreased by nearly 1/5 since 2000; Whereas the Centers for Disease Control and Prevention, partnering with other entities of the United States and individual States and territories, directs the national TB elimination program, coordinates TB surveillance, technical assistance, and prevention activities, and helps to support the development of new diagnostic, treatment, and prevention tools to combat TB; Whereas the National Institutes of Health, through its many institutes and centers, plays the leading role in basic and clinical research on the identification, treatment, and prevention of TB; Whereas the Global Fund to Fight AIDS, Tuberculosis, and Malaria (commonly referred to as the Global Fund ), to which the United States is a top financial donor, provides more than 65 percent of all international financing for TB programs; Whereas, to date, Global Fund-supported programs have detected and treated 17,400,000 cases of TB